Friday marked the closing date for entries to the competition to select the menu for the Gala Dinner which the Chartered Institute of Patent Attorneys (CIPA) will shortly be holding as the centrepiece of this year's Congress (click here for programme details: you may still have the chance to register!). The IPKat received many emails on the subject, some offering a single course (happily, humble pie was not mentioned) and one offering practical tips on how to dispose of the diners' bodies afterwards.
One entry (should that be entrée?) was so much better than the rest that it would be invidious to publish the runners-up, and that -- appropriately given the surname of the successful entrant -- came from the ever-fertile pen of Philip Grubb. The winning menu runs as follows:
One entry (should that be entrée?) was so much better than the rest that it would be invidious to publish the runners-up, and that -- appropriately given the surname of the successful entrant -- came from the ever-fertile pen of Philip Grubb. The winning menu runs as follows:
SoupCongratulations, Philip, says the IPKat. You have won the prize -- complimentary registration for this year's Congress.
Claim chowder
Savoury
Pith and marrow bone
Pasta
Pozzoli con festo
Entrée
Lammy cutlets with broccoli and tomatoes
Cheese board
Kort geding (NL)
Swiss-type (CH)
Saisie (FR)
Dessert
Apple® pie à la best mode
Drinks
Free beer
Cassis de Dijon
CIPA Gala Dinner menu: Grubb's up!
Reviewed by Jeremy
on
Sunday, September 19, 2010
Rating:
Reviewed by Jeremy
on
Sunday, September 19, 2010
Rating:
Follow the IPKat on LinkedIn 
![[Guest post] Comparison of wine and gin: the EUIPO’s unquestionable Similarity Tool](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiNfTEBXiPVS0XjZi4mNE1OtXLxXiEp1PUgcUK7MMMXlfyTkO5SMXv-VCMXXNdS_F1XdMMxYca1VbBTGvvDeTVpo5x-5YwR7atQJmK3x32T8LACpf4308kht3nEtaxPwEPcGGrB0s5xjGktmQPOiVwPVLRO5JbW19qupc7xUtiVutvaWHow0OpBkA/s72-c/Picture%201.jpg)
![[Guest post] Muddying the waters of copyright – a rapid reaction to today’s IPEC decision which sees the sinking of the WaterRower’s claims for copyright protection](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh7chFANC7ppmZl4_nlR6_hZEcg6cOhVEJNVXqki4p82BoVlcLFotuOXzHWYD5lKLiiK_kRoWeXmJjjaV2DpoKsAWq8U3LFioO5W_841a9gcfDIFjvZWcGqfnr0jWJNtyXptIYR_8bxCssaDkJ9KMokuSqy1g65Il7p2hPwo4MfRCEGoUPQJesvbg/s72-w400-c-h189/Screenshot%202024-11-11%20at%2018.20.45.png)
Posts
In response to the data exclusivity query the question is whether these are new active substances. There are conflicting views that are not easily reconciled. Thus there is currently in Case T-275/09 Sepracor a challenge to a decision that an enantiomer (eszoplicone) to an already authorised racemate (zoplicone) is not a new active substance, and indeed because of this Sepracor have apparently abandoned the product in Europe. However earlier this year a number of generic authorisations for escitalopram were suspended on the basis that its data exclusivity had not been respected, which thus had the effect of treating escitalopram as a new active substance over citalopram.
ReplyDeleteShould the menu not also contain a "Razzall"? Lammy's successor as IP Minister is Tim Razzall, former partner of Frere Cholmeley.
ReplyDeleteI thought Baroness Wilcox was the current IP minister?
ReplyDeleteBaroness of Beef?
How about some Cox apples as dessert?
ReplyDelete